journal article·2025-06-19Open access

What Are the Best Biocompatible Materials for Extracorporeal Membrane Oxygenation

Junya Hagiwara, Jeffrey D. DellaVolpe, Yuichi Matsuzaki

Abstract

Extracorporeal membrane oxygenation (ECMO) is a crucial life support therapy for patients with severe cardiac and respiratory failure. However, the complications associated with venoarterial ECMO (VA-ECMO), including thrombus formation, bleeding, and hemolysis, remain significant challenges that impact patient outcomes and healthcare costs. These complications primarily arise from blood–material interactions within the ECMO circuit, necessitating the development of biocompatible materials to optimize hemocompatibility. This review provides an updated overview of the latest advancements in VA-ECMO materials, focusing on cannula, oxygenators, and centrifugal pumps. Various surface modifications, such as heparin coatings, nitric oxide-releasing polymers, phosphorylcholine (PC)-based coatings, and emerging omniphobic surfaces, have been explored to mitigate thrombosis and bleeding risks. Additionally, novel oxygenator membrane technologies, including zwitterionic polymers and endothelial-mimicking coatings, offer promising strategies to enhance biocompatibility and reduce inflammatory responses. In centrifugal pumps, magnetic levitation systems and hybrid polymer-composite impellers have been introduced to minimize shear stress and thrombogenicity. Despite these advancements, no single material has fully addressed all complications, and further research is needed to refine surface engineering strategies. This review highlights the current progress in ECMO biomaterials and discusses future directions in developing more effective and durable solutions to improve patient safety and clinical outcomes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mechanical Circulatory Support Devices · Membrane Separation Technologies · Fuel Cells and Related Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Extracorporeal Life Support, San Antonio, TX 78229, USA

Texas IPS, San Antonio, TX 78229, USA

Methodist Heart and Lung Institute Vascular Center, 4410 Medical Dr Ste 420, San Antonio, TX 78229, USA

References (100+)

Show source-provided references
1. Temporary circulatory support for cardiogenic shock10.1016/S0140-6736(20)31047-3 ↗
2. Intravascular Hemolysis and Complications During Extracorporeal Membrane Oxygenation10.1542/neo.21-11-e728 ↗
3. Hemolysis in patients with Extracorporeal Membrane Oxygenation therapy for severe Acute Respiratory Distress Syndrome—A systematic review of the literature10.7150/ijms.50217 ↗
4. Longitudinal Trends in Bleeding Complications on Extracorporeal Life Support Over the Past Two Decades-Extracorporeal Life Support Organization Registry Analysis10.1097/CCM.0000000000005466 ↗
5. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis10.1016/j.jcrc.2017.02.014 ↗
6. Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database10.1097/CCM.0000000000002502 ↗
7. In-Hospital Neurologic Complications in Adult Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation: Results From the Extracorporeal Life Support Organization Registry10.1097/CCM.0000000000001865 ↗
8. Treml, B., Breitkopf, R., Bukumirić, Z., Bachler, M., Boesch, J., and Rajsic, S. (2022). ECMO Predictors of Mortality: A 10-Year Referral Centre Experience. J. Clin. Med., 11.10.3390/jcm11051224 ↗
9. Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review10.1097/MAT.0000000000001230 ↗
10. Wickramarachchi, A., Khamooshi, M., Burrell, A., Pellegrino, V.A., Kaye, D.M., and Gregory, S.D. (2023). The effect of drainage cannula tip position on risk of thrombosis during venoarterial extracorporeal membrane oxygenation. Comput. Methods Programs Biomed., 231.10.1016/j.cmpb.2023.107407 ↗
11. Venous or arterial thromboses after venoarterial extracorporeal membrane oxygenation support: Frequency and risk factors10.1016/j.healun.2020.12.007 ↗
12. Incremental effect of complications on mortality and hospital costs in adult ECMO patients10.1177/02676591211005697 ↗
13. Fuchs, G., Berg, N., Broman, L.M., and Prahl Wittberg, L. (2018). Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit. Sci. Rep., 8.10.1038/s41598-018-32247-y ↗
14. Catastrophic Mechanical Complications of Extracorporeal Membrane Oxygenation10.1097/MAT.0000000000001354 ↗
15. Prevalence and Indications for Oxygenator Circuit Replacement in Patients Receiving Venovenous Extracorporeal Membrane Oxygenation10.1097/MAT.0000000000001977 ↗
16. Hastings lecture. Breaking the blood-biomaterial barrier
17. Extracorporeal life support: The precarious balance of hemostasis10.1111/jth.12963 ↗
18. Frantzeskaki, F., Konstantonis, D., Rizos, M., Kitsinelis, V., Skyllas, G., Renieris, I., Doumani, M., Kolias, V., Kefalidi, E., and Angouras, D. (2023). Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults. Diagnostics, 13.10.20944/preprints202310.1071.v1 ↗
19. Heparin Bonding on Colloidal Graphite Surfaces10.1126/science.142.3597.1297 ↗
20. Heparin-bonded circuits versus nonheparin-bonded circuits: An evaluation of their effect on clinical outcomes10.1016/j.ejcts.2007.01.029 ↗
21. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome10.1016/j.athoracsur.2008.09.076 ↗
22. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: A population-based study10.1016/S2352-3026(18)30046-2 ↗
23. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)—Relationship between protein adsorption and platelet adhesion on PMEA surface10.1016/S0142-9612(00)00031-4 ↗
24. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits10.1016/S0003-4975(02)03796-7 ↗
25. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass10.1046/j.1525-1594.2000.06520.x ↗
26. A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass10.1177/0267659115598217 ↗
27. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery10.1007/s10047-016-0887-8 ↗
28. Changes in platelet aggregation during cardiopulmonary bypass: Comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material10.1007/s10047-004-0280-x ↗
29. A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: A preliminary experience10.1177/0267659112469642 ↗
30. Hollow fiber membrane modification with functional zwitterionic macromolecules for improved thromboresistance in artificial lungs10.1021/la504907m ↗
31. Significantly reduced adsorption and activation of blood components in a membrane oxygenator system coated with crosslinkable zwitterionic copolymer10.1016/j.actbio.2016.02.036 ↗
32. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: The intraoperative ECMO concept10.1177/039139880202500910 ↗
33. Reduced systemic heparin dose with phosphorylcholine coated closed circuit in coronary operations10.1177/039139880402700407 ↗
34. Comparison of the effects of phosphorylcholin versus heparin-based surface coating on clinical and histologic outcomes during veno-arterial extracorporeal membrane oxygenation support: A propensity score weighted analysis10.1016/j.jtha.2025.02.020 ↗
35. The artificial endothelium10.4161/org.7.1.14029 ↗
36. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation10.1177/0267659107080877 ↗
37. In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive10.1039/c3tb20277a ↗
38. Mimicking the Endothelium: Dual Action Heparinized Nitric Oxide Releasing Surface10.1021/acsami.9b22277 ↗
39. Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity10.1038/nature10447 ↗
40. Hemocompatibility of Super-Repellent surfaces: Current and Future10.1039/C9MH00051H ↗
41. Liquid-infused structured surfaces with exceptional anti-biofouling performance10.1073/pnas.1201973109 ↗
42. A biomimetic approach towards a universal slippery liquid infused surface coating10.3762/bjnano.15.111 ↗
43. Badv, M., Jaffer, I.H., Weitz, J.I., and Didar, T.F. (2017). An omniphobic lubricant-infused coating produced by chemical vapor deposition of hydrophobic organosilanes attenuates clotting on catheter surfaces. Sci. Rep., 7.10.1038/s41598-017-12149-1 ↗
44. Antifouling Zwitterionic Polymer Coatings for Blood-Bearing Medical Devices10.1021/acs.langmuir.4c04532 ↗
45. Durable plasma-mediated zwitterionic grafting on polymeric surfaces for implantable medical devices10.1038/s43246-024-00462-y ↗
46. Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study10.1097/MAT.0000000000001055 ↗
47. Tethered Liquid Perfluorocarbon Coating for 72 Hour Heparin-Free Extracorporeal Life Support10.1097/MAT.0000000000001292 ↗
48. Gao, W., Wang, H., Liu, Y., Tang, Q., Wu, P., Lin, T., Li, T., and Sun, D. (2022). Sodium alginate-hydrogel coatings on extracorporeal membrane oxygenation for anticoagulation. Front. Cardiovasc. Med., 9.10.3389/fcvm.2022.966649 ↗
49. Microgel reinforced zwitterionic hydrogel coating for blood-contacting biomedical devices10.1038/s41467-022-33081-7 ↗
50. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization—A review of current strategies10.1016/j.biotechadv.2009.10.005 ↗
51. Toward an artificial endothelium: Development of blood-compatible surfaces for extracorporeal life support10.1097/TA.0000000000002700 ↗
52. Interactive Hemocompatible Nanocoating to Prevent Surface-Induced Coagulation in Medical Devices10.1002/admi.202201055 ↗
53. Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates10.1002/rth2.12309 ↗
54. Rim, G., Hyun, K., Cho, D.G., Lim, Z., Lee, B., Kim, K., and Yoo, G.Y. (2024). Early thrombus detection in the extracorporeal membrane oxygenation circuit by noninvasive real-time ultrasonic sensors. Sci. Rep., 14.10.1038/s41598-024-59873-z ↗
55. Evaluation of Capiox RX25 and Quadrox-i Adult Hollow Fiber Membrane Oxygenators in a Simulated Cardiopulmonary Bypass Circuit10.1111/aor.12633 ↗
56. A clinical evaluation of the Maquet Quadrox-i Neonatal oxygenator with integrated arterial filter10.1177/0267659113475694 ↗
57. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients10.1053/j.jvca.2018.07.045 ↗
58. Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO)10.1007/s42114-021-00244-x ↗
59. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications10.1039/C4CS00483C ↗
60. Design of hemocompatible and antifouling PET sheets with synergistic zwitterionic surfaces10.1016/j.jcis.2016.07.022 ↗
61. Obstals, F., Vorobii, M., Riedel, T., de Los Santos Pereira, A., Bruns, M., Singh, S., and Rodriguez-Emmenegger, C. (2018). Improving Hemocompatibility of Membranes for Extracorporeal Membrane Oxygenators by Grafting Nonthrombogenic Polymer Brushes. Macromol. Biosci., 18.10.1002/mabi.201700359 ↗
62. Silicone elastomers for reduced protein adsorption10.1016/j.biomaterials.2003.09.023 ↗
63. Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide)10.1016/j.biomaterials.2004.07.068 ↗
64. Antibacterial and hemocompatibility switchable polypropylene nonwoven fabric membrane surface10.1021/am401098u ↗
65. Surface modifying additives for improved device-blood compatibility10.1097/00002480-199407000-00073 ↗
66. Free radical graft polymerization of 2-hydroxyethyl methacrylate and acrylic acid on the polysulfone membrane surface through circulation of reaction media to improve its performance and hemocompatibility properties10.1016/j.memsci.2018.07.071 ↗
67. Surface coating of stearyl poly(ethylene oxide) coupling-polymer on polyurethane guiding catheters with poly(ether urethane) film-building additive for biomedical applications10.1016/S0142-9612(00)00311-2 ↗
68. Antithrombogenic investigation of surface energy and optical bandgap and hemocompatibility mechanism of Ti(Ta+5)O2 thin films10.1016/S0142-9612(01)00389-1 ↗
69. Creating long-lived superhydrophobic polymer surfaces through mechanically assembled monolayers10.1126/science.290.5499.2130 ↗
70. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
71. Polymer surface modification for the attachment of bioactive compounds10.1016/j.progpolymsci.2007.04.002 ↗
72. Covalent deposition of zwitterionic polymer and citric acid by click chemistry-enabled layer-by-layer assembly for improving the blood compatibility of polysulfone membrane10.1021/la5001705 ↗
73. Layer by layer assembled phosphorylcholine groups on paclitaxel/chitosan nanofibers coatings for hemocompatibility improvement10.1016/j.surfcoat.2018.10.074 ↗
74. Controlled surface chemistry of diamond/β-SiC composite films for preferential protein adsorption10.1021/la404277p ↗
75. Platelet adhesion onto chargeable functional group gradient surfaces10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H ↗
76. Zhang, Q., Dong, J., Peng, M., Yang, Z., Wan, Y., Yao, F., Zhou, J., Ouyang, C., Deng, X., and Luo, H. (2020). Laser-induced wettability gradient surface on NiTi alloy for improved hemocompatibility and flow resistance. Mater. Sci. Eng. C Mater. Biol. Appl., 111.10.1016/j.msec.2020.110847 ↗
77. Prudnikov, E., Polishchuk, I., Sand, A., Hamad, H.A., Massad-Ivanir, N., Segal, E., and Pokroy, B. (2023). Self-assembled fatty acid crystalline coatings display superhydrophobic antimicrobial properties. Mater. Today Bio, 18.10.1016/j.mtbio.2022.100516 ↗
78. How to make water run uphill10.1126/science.256.5063.1539 ↗
79. Endothelial cell-cell junctions: Happy together10.1038/nrm1357 ↗
80. A biological alternative to alloplastic grafts in dialysis therapy: Evaluation of an autologised bioartificial haemodialysis shunt vessel in a sheep model10.1016/j.ejvs.2010.04.023 ↗
81. The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants10.1016/j.biomaterials.2010.08.073 ↗
82. In situ Endothelialization: Bioengineering Considerations to Translation10.1002/smll.201402579 ↗
83. Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung10.1016/j.actbio.2016.12.017 ↗
84. Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes
85. Blood-Compatible Surfaces with Phosphorylcholine-Based Polymers for Cardiovascular Medical Devices10.1021/acs.langmuir.8b01565 ↗
86. Surface passivation by human albumin of plasmapheresis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studies10.1002/jbm.820240203 ↗
87. Kuchinka, J., Willems, C., Telyshev, D.V., and Groth, T. (2021). Control of Blood Coagulation by Hemocompatible Material Surfaces—A Review. Bioengineering, 8.10.3390/bioengineering8120215 ↗
88. Burzava, A.L.S., Jasieniak, M., Cockshell, M.P., Voelcker, N.H., Bonder, C.S., Griesser, H.J., and Moore, E. (2022). Attachment of endothelial colony-forming cells onto a surface bearing immobilized anti-CD34 antibodies: Specific CD34 binding versus nonspecific binding. Biointerphases, 17.10.1116/6.0001746 ↗
89. Li, S., Atkinson, H.M., Fusch, G., Rochow, N., Fusch, C., Selvaganapathy, P.R., Brash, J.L., Chan, A.K.C., and Sask, K.N. (2025). Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity. Biomater. Adv., 166.10.1016/j.bioadv.2024.214067 ↗
90. Witzdam, L., Sandhu, S., Shin, S., Hong, Y., Kamal, S., Grottke, O., Cook, K.E., and Rodriguez-Emmenegger, C. (2025). Enhancing Hemocompatibility in ECMO Systems With a Fibrinolytic Interactive Coating: In Vitro Evaluation of Blood Clot Lysis Using a 3D Microfluidic Model. Macromol. Biosci., 25.10.1002/mabi.202400530 ↗
91. Novel polymer composite coated with ethylcellulose nanoparticle from waste paper as an alternative material to extracorporeal oxygenation membrane10.1007/s10965-023-03576-y ↗
92. Superamphiphobic blood-repellent surface modification of porous fluoropolymer membranes for blood oxygenation applications10.1016/j.memsci.2022.120363 ↗
93. Türkmen, M., Lauwigi, T., Fechter, T., Gries, F., Fischbach, A., Gries, T., Rossaint, R., Bleilevens, C., and Winnersbach, P. (2023). Bioimpedance Analysis as Early Predictor for Clot Formation Inside a Blood-Perfused Test Chamber: Proof of Concept Using an In Vitro Test-Circuit. Biosensors, 13.10.3390/bios13030394 ↗
94. Blood Pumps for Extracorporeal Membrane Oxygenation: Platelet Activation During Different Operating Conditions10.1097/MAT.0000000000001493 ↗
95. Thrombosis in centrifugal pumps: Location and composition in clinical and in vitro circuits10.5301/ijao.5000498 ↗
96. Schibilsky, D., Takatani, S., Schibilsky, B., Graf, T., da Silva, D.M., Wendel, H.P., Avci-Adali, M., and Schlensak, C. (2020). Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump. Sci. Rep., 10.10.1038/s41598-020-78709-0 ↗
97. Miniaturized soft centrifugal pumps with magnetic levitation for fluid handling10.1126/sciadv.abi7203 ↗
98. Ding, S., Chen, J., Wu, Y., Lin, H., Liang, Q., Teng, G., Liu, Z., and Huang, M. (2025). Application of a novel extracorporeal membrane oxygenation system in awake Hu sheep under various durations. BMC Anesthesiol., 25.10.1186/s12871-025-02930-5 ↗
99. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial10.1016/j.healun.2019.05.006 ↗
100. Abdul Samad, M. (2021). Recent Advances in UHMWPE/UHMWPE Nanocomposite/UHMWPE Hybrid Nanocomposite Polymer Coatings for Tribological Applications: A Comprehensive Review. Polymers, 13.10.3390/polym13040608 ↗